Trial Profile
Impact of Lofexidine on Stress, Craving and Opioid Use
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Apr 2024
Price :
$35
*
At a glance
- Drugs Lofexidine (Primary)
- Indications Opioid-related disorders
- Focus Therapeutic Use
- 05 Apr 2024 Status changed from recruiting to completed.
- 16 Nov 2023 Planned End Date changed from 31 Dec 2023 to 29 Feb 2024.
- 16 Nov 2023 Planned primary completion date changed from 31 Dec 2023 to 29 Feb 2024.